Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
Acta Pharmaceutica · 01.06.2023 · 73 (2) · 227-241
DOI: 10.2478/acph-2023-0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, online erschienen am 12.06.2023. Verfasst von Javier Muriel und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1Neuropharmacology applied to Pain (NED) Alicante Institute for Health and Biomedical Research (ISABIAL), c/Pintor Baeza, 12 03010, Alicante, Spain. Hauptthemen laut MEDLINE: Chronic Pain, Tramadol, Deprescriptions, Opioid-Related Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Sucht und Abhängigkeit, Schmerzmanagement
Abstract (Originalsprache)
More than half of patients with opioid use disorder for chronic non-cancer pain (CNCP) reduced their dose through a progressive opioid withdrawal supported by a rotation to buprenorphine and/or tramadol. The aim of this research is to analyse the long-term effectiveness of opioid deprescription taking into account the impact of sex and pharmacogenetics on the inter-individual variability. A cross-sectional study was carried out from October 2019 to June 2020 on CNCP patients who had previously undergone an opioid deprescription ( n = 119 patients). Demographic, clinical (pain, relief and adverse events) and therapeutic (analgesic use) outcomes were collected. Effectiveness (< 50 mg per day of morphine equivalent daily dose without any aberrant opioid use behaviour) and safety (number of side-effects) were analysed in relation to sex differences and pharmacogenetic markers impact [ OPRM1 genotype (rs1799971) and CYP2D6 phenotypes]. Long-term opioid deprescription was achieved in 49 % of the patients with an increase in pain relief and a reduction of adverse events. CYP2D6 poor metabolizers showed the lowest long-term opioid doses. Here, women showed a higher degree of opioid deprescription, but increased use of tramadol and neuromodulators, as well as an increased number of adverse events. Long-term deprescription was successful in half of the cases. Understanding sex and gender interaction plus a genetic impact could help to design more individualized strategies for opioid deprescription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Neuropharmacology applied to Pain (NED) Alicante Institute for Health and Biomedical Research (ISABIAL), c/Pintor Baeza, 12 03010, Alicante, Spain.
- 2Institute of Bioengineering, Miguel Hernández University, Avda. de la Universidad s/n, 03202, Elche, Spain.
- 3Pain Unit, Dr. Balmis General University Hospital, ISABIAL, c/Pintor Baeza, 12 03010, Alicante, Spain.
- 4Operations Research Centre, Miguel Hernández University, Avda. de la Universidad s/n, 03202, Elche, Spain.
- 5Clinical Pharmacology Department, Dr. Balmis General University Hospital ISABIAL, c/Pintor Baeza, 12, 03010 Alicante, Spain.
ORCID-Profile: Javier Muriel, Mónica Escorial, César Margarit, Jordi Barrachina, Cristian Carvajal, Domingo Morales, Ana M Peiró
Zitieren
APA
Muriel, J., Escorial, M., Margarit, C., Barrachina, J., Carvajal, C., Morales, D., & Peiró, A. M. (2023). Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. Acta Pharmaceutica, 73(2), 227-241. https://doi.org/10.2478/acph-2023-0018
Vancouver
Muriel J, Escorial M, Margarit C, Barrachina J, Carvajal C, Morales D, et al. Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. Acta Pharmaceutica. 2023;73(2):227-241. doi:10.2478/acph-2023-0018
BibTeX
@article{Muriel2023,
author = {Muriel, Javier and Escorial, Mónica and Margarit, César and Barrachina, Jordi and Carvajal, Cristian and Morales, Domingo and Peiró, Ana M},
title = {Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences},
journal = {Acta Pharmaceutica},
year = {2023},
volume = {73},
number = {2},
pages = {227--241},
doi = {10.2478/acph-2023-0018}
}
EUVIMED